$3.15+0.02 (+0.66%)
DNA X, Inc.
DNA X, Inc. in the Technology sector is trading at $3.15 with a market capitalization of $7M. The stock is currently near its 52-week low of $2.52, remaining 45.4% below its 200-day moving average. On fundamentals, Piotroski 1/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 25/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $0β | -$44.13Mβ | $16.21Mβ | $11.19M | $0 |
| Gross Profit | β | -$11.02Mβ | $1.82Mβ | $845,000β | $8.36M |
| Operating Income | -$3.62Mβ | $4.66Mβ | -$3.98Mβ | -$6.73Mβ | -$870,000 |
| Net Income | $6.34Mβ | -$8.89Mβ | -$4.75Mβ | -$7.47Mβ | $458,000 |
DNA X, Inc. provides enterprise 5G solutions in the United States, Canada, Europe, the Middle East, and the Asia Pacific. The company offers ruggedized cell phones for task workers, which include Sonim XP10, Sonim XP5plus, Sonim XP3plus, and Sonim XP...